🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial is studying the side effects and best dose of capecitabi...
Status
Completed
Location
City of Hope
Start Date
2004-05
Trial ID
NCT00084643
Treatments Being Tested
This phase I trial is studying the side effects and best dose of GTI-2040 i...
Status
Completed
Location
City of Hope Medical Center
Start Date
2007-03
Trial ID
NCT00459212
Treatments Being Tested
This phase II, 43 patient trial, will evaluate the efficacy of GTI-2040, an...
Status
Completed
Location
Bay Area Cancer Research Group
Start Date
2002-03
Trial ID
NCT00056173
Treatments Being Tested
This phase I trial is studying the side effects and best dose of GTI-2040 a...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2003-09
Trial ID
NCT00070551
Treatments Being Tested
Phase I/II trial to study the effectiveness of combining GTI-2040 with doce...
Status
Completed
Location
Princess Margaret Hospital Phase 2 Consortium
Start Date
2003-10
Trial ID
NCT00074022
Treatments Being Tested
This is a Phase II trial conducted at multiple centers for evaluation of th...
Status
Completed
Location
San Francisco Veterans Affairs Medical Center
Start Date
2007-08
Trial ID
NCT00565058
Treatments Being Tested
This phase I trial is studying the side effects and best dose of GTI-2040 a...
Status
Completed
Location
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
Start Date
2004-01
Trial ID
NCT00078962
Treatments Being Tested
This phase II trial is studying how well giving GTI-2040 together with cape...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2003-10
Trial ID
NCT00068588
Treatments Being Tested
RATIONALE: GTI-2040 may stop the growth of tumor cells by blocking the enzy...
Status
Completed
Location
British Columbia Cancer Agency - Vancouver Cancer Centre
Start Date
2005-01
Trial ID
NCT00087165
Treatments Being Tested